Opinion: Breakthrough Therapies Act: Good idea, wrong solution
STAT
DECEMBER 2, 2022
as a way to expand access for therapeutic purposes to potentially beneficial but highly regulated Schedule I substances like psilocybin and LSD, has the right underlying idea but provides a solution that is wrong. The Breakthrough Therapies Act , recently proposed by Senators Rand Paul (R-Ky.) and Cory Booker (D-N.J.)
Let's personalize your content